CSIMarket
 


Opgen inc   (OPGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

OPGN's Capital Expenditures Growth by Quarter and Year

Opgen Inc 's Capital Expenditures results by quarter and year




OPGN Capital Expenditures (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.40 0.16 0.13
III Quarter September 0.10 0.10 0.10 0.00
II Quarter June 0.37 0.04 0.87 0.00
I Quarter March 0.33 0.04 0.85 0.00
FY   0.80 0.58 1.98 0.13



OPGN Capital Expenditures third quarter 2023 Y/Y Growth Comment
Opgen inc reported Capital Expenditures growth of 1.74% year on year in the third quarter 2023, to $ 0.10 millions, this is lower than Opgen Inc 's recent average Capital Expenditures improvement of 39.11%.

Looking into third quarter 2023 results within Medical Laboratories industry 9 other companies have achieved higher Capital Expenditures growth. While Opgen Inc ' s Capital Expenditures increase of 1.74% ranks overall at the positon no. 1158 in the third quarter 2023.




OPGN Capital Expenditures ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 150 % 23.08 % -
III Quarter September 1.74 % 0 % - -
II Quarter June 825 % -95.4 % - -
I Quarter March 725 % -95.29 % - -
FY   - -70.71 % 1423.08 % 62.5 %

Financial Statements
Opgen Inc 's third quarter 2023 Capital Expenditures $ 0.10 millions OPGN's Income Statement
Opgen Inc 's third quarter 2022 Capital Expenditures $ 0.10 millions Quarterly OPGN's Income Statement
New: More OPGN's historic Capital Expenditures Growth >>


OPGN Capital Expenditures (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 300 % 60 % -
III Quarter September -72.5 % 150 % -88.51 % -
II Quarter June 12.12 % 0 % 2.35 % -
I Quarter March -17.5 % -75 % 553.85 % -
FY (Year on Year)   - -70.71 % 1423.08 % 62.5 %




Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #156
Overall #1158

Capital Expenditures Y/Y Growth Statistics
High Average Low
250.17 % 39.11 % -84.39 %
(Jun 30 2023)   (Mar 31 2020)
Capital Expenditures third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #156
Overall #1158
Capital Expenditures Y/Y Growth Statistics
High Average Low
250.17 % 39.11 % -84.39 %
(Jun 30 2023)   (Mar 31 2020)

Capital Expenditures by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Opgen Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
9048.71 % 479.61 % -100 %
(Dec 31 2020)  


OPGN's III. Quarter Q/Q Capital Expenditures Comment
In the III. Quarter 2023 Opgen Inc disclosed fall in Capital Expenditures sequentially by -72.5% to $ 0.10 millions, from $ 0.37 millions declared in the previous reporting period.

Although cyclical factors usually elevate III. Quarter 2023 performance, it simply has not been substantial to recover Opgen Inc 's III. Quarter 2023 performance, Lander Peeters, Medical Laboratories industry researcher allocated in Frankfurt wrote.

Within Medical Laboratories industry 31 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Opgen Inc 's Capital Expenditures growth quarter on quarter, overall rank is 3063.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #32
Healthcare Sector #519
Overall #3063
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #32
Healthcare Sector #519
Overall #3063
Capital Expenditures Q/Q Growth Statistics
High Average Low
9048.71 % 479.61 % -100 %
(Dec 31 2020)  


OPGN's III. Quarter Q/Q Capital Expenditures Comment
In the III. Quarter 2023 Opgen Inc realized fall in Capital Expenditures from the previous quarter by -72.5% to $ 0.10 millions, from $ 0.37 millions released in the previous quarter.

Those periodic influence have not rescue the III. Quarter for the Opgen inc , Lander Peeters, Medical Laboratories industry researcher allocated in Frankfurt pointed out, he mentioned certan caution conserning OPGN's perspective, he identified further difficulties ahead for OPGN and continued that average quarter on quarter Capital Expenditures growth is at 479.61% for OPGN.

Within Medical Laboratories industry 31 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Opgen Inc 's Capital Expenditures growth quarter on quarter, overall rank is 3063.


Opgen Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Capital Expenditures 12 Months Ending $ 1.20 $ 1.20 $ 0.88 $ 0.59 $ 0.35
Y / Y Capital Expenditures Growth (TTM) 248.49 % 250.17 % -24.67 % -70.22 % -82.31 %
Year on Year Capital Expenditures Growth Overall Ranking # 2008 # 2027 # 1953 # 2434 # 2095
Seqeuential Capital Expenditures Change (TTM) -0.1 % 36.54 % 49.38 % 71.04 % 0.38 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1158 # 1971 # 1741 # 1585 # 1638




Cumulative Capital Expenditures growth Comment
Assuming the Opgen Inc 's fiscal year would have ended in Sep 30 2023, Opgen Inc would have reprted above average annual Capital Expenditures surge of 248.49% year on year, of $ 1 millions.
This marks a slow-down of the companys growth trends and from the 250.17% surge in Jun 30 2023.

In the Healthcare sector 344 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 2008, from total ranking in previous quarter at 2027.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
250.17 %
39.11 %
-84.39 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 10
Healthcare Sector # 345
Overall # 2008

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
250.17 %
39.11 %
-84.39 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 156
S&P 500 # 1158
Cumulative Capital Expenditures growth Comment
Assuming the Opgen Inc 's fiscal year would have ended in Sep 30 2023, Opgen Inc would have reprted above average annual Capital Expenditures surge of 248.49% year on year, of $ 1 millions.
This marks a slow-down of the companys growth trends and from the 250.17% surge in Jun 30 2023.

In the Healthcare sector 344 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Total ranking has impoved so far to 2008, from total ranking in previous quarter at 2027.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
250.17 %
39.11 %
-84.39 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 10
Healthcare Sector # 345
Overall # 2008

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
250.17 %
39.11 %
-84.39 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 156
S&P 500 # 1158




Other Capital Expenditures Growth
Medical Laboratories Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
OPGN's Capital Expenditures Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for OPGN's Competitors
Capital Expenditures Growth for Opgen Inc 's Suppliers
Capital Expenditures Growth for OPGN's Customers

You may also want to know
OPGN's Annual Growth Rates OPGN's Profitability Ratios OPGN's Asset Turnover Ratio OPGN's Dividend Growth
OPGN's Roe OPGN's Valuation Ratios OPGN's Financial Strength Ratios OPGN's Dividend Payout Ratio
OPGN's Roa OPGN's Inventory Turnover Ratio OPGN's Growth Rates OPGN's Dividend Comparisons



Companies with similar Capital Expenditures surge for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Sep 30 2023
Co diagnostics Inc 2.83%$ 2.834 millions
Springworks Therapeutics Inc 2.66%$ 2.664 millions
Owens and Minor inc2.30%$ 2.303 millions
Hca Healthcare Inc 1.41%$ 1.415 millions
Sharecare Inc 1.24%$ 1.236 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com